These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 33947272

  • 1. Changes in Thyrotropin Receptor Antibody Levels Following Total Thyroidectomy or Radioiodine Therapy in Patients with Refractory Graves' Disease.
    Kim J, Choi MS, Park J, Park H, Jang HW, Choe JH, Kim JH, Kim JS, Cho YS, Choi JY, Kim TH, Chung JH, Kim SW.
    Thyroid; 2021 Aug; 31(8):1264-1271. PubMed ID: 33947272
    [Abstract] [Full Text] [Related]

  • 2. A prospective study of the changes in thyrotropin binding inhibitory immunoglobulins in Graves' disease treated by subtotal thyroidectomy or radioactive iodine.
    Teng CS, Yeung RT, Khoo RK, Alagaratnam TT.
    J Clin Endocrinol Metab; 1980 Jun; 50(6):1005-10. PubMed ID: 6103007
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Postoperative changes in thyrotropin-binding inhibitory immunoglobulin level in patients with Graves' disease: is subtotal thyroidectomy a suitable therapeutic option for patients of childbearing age with Graves' disease?
    Sugino K, Ito K, Ozaki O, Mimura T, Iwasaki H, Wada N.
    World J Surg; 1999 Jul; 23(7):727-31. PubMed ID: 10390595
    [Abstract] [Full Text] [Related]

  • 6. Remission of Graves' hyperthyroidism predicted by smooth decreases of thyroid-stimulating antibody and thyrotropin-binding inhibitor immunoglobulin during antithyroid drug treatment.
    Takasu N, Yamashiro K, Komiya I, Ochi Y, Sato Y, Nagata A.
    Thyroid; 2000 Oct; 10(10):891-6. PubMed ID: 11081255
    [Abstract] [Full Text] [Related]

  • 7. Impaired Quality of Life After Radioiodine Therapy Compared to Antithyroid Drugs or Surgical Treatment for Graves' Hyperthyroidism: A Long-Term Follow-Up with the Thyroid-Related Patient-Reported Outcome Questionnaire and 36-Item Short Form Health Status Survey.
    Törring O, Watt T, Sjölin G, Byström K, Abraham-Nordling M, Calissendorff J, Cramon PK, Filipsson Nyström H, Hallengren B, Holmberg M, Khamisi S, Lantz M, Wallin G.
    Thyroid; 2019 Mar; 29(3):322-331. PubMed ID: 30667296
    [Abstract] [Full Text] [Related]

  • 8. The success rate of radioactive iodine therapy for Graves' disease in iodine-replete area and affecting factors: a single-center study.
    Park H, Kim HI, Park J, Park SY, Kim TH, Chung JH, Choi JY, Kim SW.
    Nucl Med Commun; 2020 Mar; 41(3):212-218. PubMed ID: 31895759
    [Abstract] [Full Text] [Related]

  • 9. Does thyroidectomy, radioactive iodine therapy, or antithyroid drug treatment alter reactivity of patients' T cells to epitopes of thyrotropin receptor in autoimmune thyroid diseases?
    Soliman M, Kaplan E, Abdel-Latif A, Scherberg N, DeGroot LJ.
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2312-21. PubMed ID: 7543112
    [Abstract] [Full Text] [Related]

  • 10. Specific effects of radioiodine treatment on TSAb and TBAb levels in patients with Graves' disease.
    Michelangeli VP, Poon C, Topliss DJ, Colman PG.
    Thyroid; 1995 Jun; 5(3):171-6. PubMed ID: 7580264
    [Abstract] [Full Text] [Related]

  • 11. Changes in thyrotropin receptor antibody after subtotal thyroidectomy in Graves' disease: comparison with the degree of lymphocytic infiltration in the thyroid.
    Cho BY, Oh SK, Shong YK, Kim SE, Yoo HY, Lee HK, Koh CS, Min HK.
    Autoimmunity; 1990 Jun; 8(2):143-7. PubMed ID: 1983330
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Patterns of Use, Efficacy, and Safety of Treatment Options for Patients with Graves' Disease: A Nationwide Population-Based Study.
    Brito JP, Payne S, Singh Ospina N, Rodriguez-Gutierrez R, Maraka S, Sangaralingham LR, Iñiguez-Ariza NM, Montori VM, Stan MN.
    Thyroid; 2020 Mar; 30(3):357-364. PubMed ID: 31973681
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Management of Graves Thyroidal and Extrathyroidal Disease: An Update.
    Kahaly GJ.
    J Clin Endocrinol Metab; 2020 Dec 01; 105(12):3704-20. PubMed ID: 32929476
    [Abstract] [Full Text] [Related]

  • 19. Characterization of thyroid-stimulating blocking antibodies that appeared during transient hypothyroidism after radioactive iodine therapy.
    Kung AW, Lau KS, Kohn LD.
    Thyroid; 2000 Oct 01; 10(10):909-17. PubMed ID: 11081257
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.